22 June 2023
Tekcapital plc
("Tekcapital" or the "Company")
Results of Annual General Meeting
Tekcapital Plc (AIM: TEK, OTCQB: TEKCF), the UK intellectual property investment group focused on creating valuable products from investing in university technologies that can improve quality of life, is pleased to announce that, following its Annual General Meeting held earlier today, all resolutions were duly passed with proxy voting results as follows below.
| RESOLUTION MATTER | VOTES FOR | VOTES AGAINST | VOTES WITHHELD | VOTES TOTAL |
| To receive and adopt the Annual Report and Accounts for the financial year ended 31 December 2022. | 31,569,240 | 148,703 | 6,547 | 31,717,943 |
| To re-appoint MacIntyre Hudson LLP as auditor of the company until the conclusion of the next annual general meeting at which the accounts are laid. | 31,510,640 | 209,203 | 4,647 | 31,719,843 |
| To authorise the directors of the Company to set the auditor's remuneration. | 31,521,836 | 149,203 | 53,451 | 31,671,039 |
| To re-elect Mr Louis Castro as a director of the Company. | 31,305,640 | 264,563 | 154,287 | 31,570,203 |
| To re-elect Lord David Lindsay Willetts as a director of the Company. | 31,266,835 | 303,368 | 154,287 | 31,570,203 |
| To re-elect Dr. Clifford Mark Gross as a director of the Company. | 31,398,858 | 280,181 | 45,451 | 31,679,039 |
| To re-elect Dr. Robert Clell Miller as a director of the Company. | 31,305,640 | 264,563 | 154,287 | 31,570,203 |
| That the Directors be authorised to allot shares in the Company. | 30,500,407 | 1,173,632 | 50,451 | 31,674,039 |
| To disapply pre-emption right under Section 561(1) of the Companies Act 2006. | 30,702,406 | 986,633 | 35,451 | 31,689,039 |
About Tekcapital plc
Tekcapital creates value from investing in new, university-developed discoveries that can enhance people's lives and provides a range of technology transfer services to help organisations evaluate and commercialise new technologies. Tekcapital is quoted on the AIM market of the London Stock Exchange (AIM: symbol TEK) and is headquartered in the UK. For more information, please visit www.tekcapital.com.
LEI: 213800GOJTOV19FIFZ85
For further information, please contact:
| Tekcapital Plc | | Via Flagstaff |
| Clifford M. Gross, Ph.D. | | |
| | | |
| SP Angel Corporate Finance LLP (Nominated Adviser and Broker) | | +44 (0) 20 3470 0470 |
| Richard Morrison/Charlie Bouverat (Corporate Finance) Abigail Wayne / Rob Rees (Corporate Broking) | | |
| | | |
| Flagstaff Strategic and Investor Communications |
| +44 (0) 20 7129 1474 |
| Tim Thompson/Andrea Seymour/Fergus Mellon | |
|
This press release is for informational purposes only. The information herein does not constitute investment advice nor an offer to invest and may contain statements related to our future business and financial performance and future events or developments involving Salarius that may constitute forward-looking statements. These statements may be identified by words such as "expect," "look forward to," "anticipate" "intend," "plan," "believe," "seek," "estimate," "will," "project" or words of similar meaning. We may also make forward-looking statements in other reports, in presentations, in material delivered to customers, stakeholders and in press releases. In addition, our representatives may from time to time make oral forward-looking statements. Such statements may be based on the current expectations and certain assumptions of Salarius' and/or Tekcapital's management. Please note that these are subject to a number of risks, uncertainties and factors, including, but not limited to those described in various disclosures. Should one or more of these risks or uncertainties materialize, or should underlying expectations not occur or assumptions prove incorrect, actual results, performance or achievements of Salarius or Tekcapital may vary materially from those described explicitly or implicitly in the relevant forward-looking statement. Neither Salarius nor Tekcapital intends, nor assumes any obligation, to update or revise these forward-looking statements in light of developments which differ from those anticipated.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.